Xcout Intel
Celerion competitors & alternatives
The 12 closest competitors and alternatives to Celerion among biotech companies — ranked by similarity to what Celerion actually does, not by market-cap band.
Subscribe to see Celerion’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Celerion
Celerion operates as an early-phase clinical research contract research organization (CRO) providing bioanalytical sciences, drug development, and regulatory services to pharmaceutical and biotechnology companies. The company conducts early-phase clinical trials, pharmacokinetic and pharmacodynamic analysis, immunogenicity testing, and biomarker analysis to accelerate drug development processes.
Celerion at a glance
Celerion is a biotech company headquartered in United States. Xcout tracks 8 named people at Celerion, including JoAnne Rosal (Chief Financial and Administrative Officer). Xcout recorded 90 job postings from Celerion in the last 90 days.
Celerion leadership
- JoAnne RosalChief Financial and Administrative Officer
- Susan ThorntonChief Executive Officer
- Abby K. FerraroExecutive Vice President and General Counsel
- Chad BriscoeExecutive Vice President, Global Bioanalytical Sciences
- David MayaExecutive Vice President, Global Business Development
- Michelle CombsExecutive Vice President, Data Management & Biometrics
2 more named people on record for Celerion, with roles, board committees and tenure — see the full roster →
Hiring at Celerion
Xcout recorded 90 job postings from Celerion in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Celerion's hiring signals →
Top 12 Celerion competitors
Ranked by semantic similarity — how close each company is to Celerion by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Worldwide Clinical Trials is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology companies. The company offers end-to-end solutions, including early and late phase clinical trials, bioanalytical laboratory services, data management, and consulting across various therapeutic areas such as oncology, neuroscience, and rare diseases.
Similar biotech company
KABS Laboratories is a Canadian contract research organization serving pharmaceutical and biotechnology companies. It provides drug-development support including bioequivalence and bioavailability studies, pharmacokinetic research, clinical services, and analytical laboratory testing.
Biotechnology
Admescope is a preclinical contract research organization that provides tailored ADME-Tox and DMPK services for drug discovery and development companies. The company supports various drug modalities—including small molecules, peptides, oligonucleotides, antibodies, and antibody-drug conjugates—with services spanning drug metabolism, pharmacokinetics, drug interactions, and quantitative bioanalysis.
Biotechnology
Ichor Biotechnologies, Inc. operates as a pre-clinical contract research organization (CRO) that provides laboratory and research services to biotechnology and pharmaceutical companies. The company offers protein services, pharmacology services, in vivo disease models, and clinical trial support to assist clients with drug discovery and development.
Life Sciences
CellCarta operates as a global contract research organization (CRO) providing specialized laboratory testing and biomarker services to support drug development and precision medicine. The company offers a wide range of services including immunology, proteomics, genomics, histopathology, and companion diagnostic development for pharmaceutical and biotechnology clients.
Similar biotech company
BioAgilytix is a global leader in bioanalytical services with advanced laboratory facilities located in Durham, North Carolina, alongside European and Australian headquarters to support pharmaceutical and biotech development.
Similar biotech company
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Similar biotech company
Sai Life Sciences operates as a Contract Research, Development, and Manufacturing Organization (CRDMO) providing services from drug discovery to manufacturing. It serves pharmaceutical and biotech companies by offering capabilities in synthetic medicinal chemistry, biology, drug metabolism and pharmacokinetics, process development, and drug substance manufacturing.
Similar biotech company
Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region. The company organizes its diverse offerings into three principal segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 1. Research Models and Services (RMS): This division is a key supplier of high-quality rodent research models, including specially bred strains of rats and mice for experimental purposes. It also offers a comprehensive array of support services to help clients effectively utilize these models in their research and for the screening of potential non-clinical drug candidates. These include providing genetically engineered models, insourcing solutions for facility management, and diagnostic services for research animals. 2. Discovery and Safety Assessment (DSA): The DSA segment plays a crucial role in advancing early-stage drug pipelines. It delivers early-phase and in vivo discovery services focused on identifying and validating new therapeutic targets, chemical compounds, and antibodies. The ultimate goal is to prepare promising non-clinical drug and therapeutic candidates for subsequent safety evaluations. Additionally, this segment provides an extensive range of safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism studies, and pharmacokinetics. 3. Manufacturing Solutions: This segment addresses critical quality control requirements by offering in vitro methods for both routine and rapid testing of the quality of sterile and non-sterile pharmaceuticals, as well as consumer products. It also serves as a vital provider of specialized biologics testing, which is often outsourced by pharmaceutical and biotechnology companies. Furthermore, the segment supplies avian vaccine services, including specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products, all essential for vaccine production. Beyond these specialized segments, Charles River also manages contract vivarium operations, providing crucial animal housing and care facilities for its biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Similar biotech company
Vivo Bio Tech Limited is an India-based contract research organization that provides preclinical drug-discovery and development services, including in-vivo pharmacology, toxicology, and related bioanalytical work. It serves pharmaceutical and biotechnology companies developing drugs and other healthcare products.
Biotechnology & Clinical Research
Agilex Biolabs is an Australian contract research organization (CRO) providing bioanalytical services, toxicology, and clinical trial support for pharmaceutical and biotechnology companies.
Biotechnology, Clinical Research
Proxima Clinical Research is a contract research organization that provides regulatory strategy, clinical trial management, and quality assurance services for biotech, MedTech, drug, and diagnostic companies. It assists life science innovators with filings, submissions, quality systems, and post-market support to help advance their healthcare products through regulatory clearance.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Celerion and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Celerionand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →